Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duncan F Rogers

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
COPD|December 7, 2006
The role of airway secretions in COPD: pathophysiology, epidemiology and pharmacotherapeutic optionsDuncan F Rogers
Journal of Aerosol Medicine and Pulmonary Drug Delivery|August 11, 2010
New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathwaysHonYee Lai, Duncan F Rogers
Drugs|September 10, 2003
Therapy for chronic obstructive pulmonary disease in the 21st centuryLouise E Donnelly, Duncan F Rogers
Current Opinion in Pharmacology|May 27, 2008
Novel targets and drugs in inflammatory lung diseaseLouise E Donnelly, Duncan F Rogers
Pharmacology|April 1, 2015
Therapeutic options for hydrating airway mucus in cystic fibrosisBernadett E Tildy, Duncan F Rogers
Annals of Medicine|April 4, 2006
Treatment of airway mucus hypersecretionDuncan F Rogers, Peter J Barnes
Current Opinion in Allergy and Clinical Immunology|November 13, 2009
Mucus hypersecretion in asthma: intracellular signalling pathways as targets for pharmacotherapyHon Yee Lai, Duncan F Rogers
Pharmacology|December 18, 2015
Novel Therapies to Inhibit Mucus Synthesis and Secretion in Airway Hypersecretory DiseasesEmily V S Ha, Duncan F Rogers
Expert Review of Respiratory Medicine|May 19, 2010
Phytoceuticals: the new 'physic garden' for asthma and chronic obstructive pulmonary diseaseSumalatha Grandhi, Louise E Donnelly, Duncan F Rogers
Chest|May 15, 2002
Comparison of the effects of salmeterol and formoterol in patients with severe asthmaJulia A Nightingale, Duncan F Rogers, Peter J Barnes
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
COPD|December 7, 2006
The role of airway secretions in COPD: pathophysiology, epidemiology and pharmacotherapeutic optionsDuncan F Rogers
Journal of Aerosol Medicine and Pulmonary Drug Delivery|August 11, 2010
New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathwaysHonYee Lai, Duncan F Rogers
Drugs|September 10, 2003
Therapy for chronic obstructive pulmonary disease in the 21st centuryLouise E Donnelly, Duncan F Rogers
Current Opinion in Pharmacology|May 27, 2008
Novel targets and drugs in inflammatory lung diseaseLouise E Donnelly, Duncan F Rogers
Pharmacology|April 1, 2015
Therapeutic options for hydrating airway mucus in cystic fibrosisBernadett E Tildy, Duncan F Rogers
Annals of Medicine|April 4, 2006
Treatment of airway mucus hypersecretionDuncan F Rogers, Peter J Barnes
Current Opinion in Allergy and Clinical Immunology|November 13, 2009
Mucus hypersecretion in asthma: intracellular signalling pathways as targets for pharmacotherapyHon Yee Lai, Duncan F Rogers
Pharmacology|December 18, 2015
Novel Therapies to Inhibit Mucus Synthesis and Secretion in Airway Hypersecretory DiseasesEmily V S Ha, Duncan F Rogers
Expert Review of Respiratory Medicine|May 19, 2010
Phytoceuticals: the new 'physic garden' for asthma and chronic obstructive pulmonary diseaseSumalatha Grandhi, Louise E Donnelly, Duncan F Rogers
Chest|May 15, 2002
Comparison of the effects of salmeterol and formoterol in patients with severe asthmaJulia A Nightingale, Duncan F Rogers, Peter J Barnes
Pageof 3